# The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension

> **NCT01679652** · PHASE2 · COMPLETED · sponsor: **Erling Bjerregaard Pedersen** · enrollment: 25 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01679652
- **Lead sponsor:** Erling Bjerregaard Pedersen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01679652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01679652, "The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01679652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*